Invitation to press and analyst briefing on the Year-End Report

Friday, February 10, 10:30 a.m, (CET) at Operaterrassen, Stockholm.

Bengt Ågerup, CEO and Erika Kjellberg Eriksson, CFO, will present the company and comment on the report. Moderator: Kristofer Liljeberg Svensson, Carnegie To participate, please register in one of the following ways: at or by phone + 46(0) 8 411 43 80. Friday’s presentation can also be followed live by telephone conference, which is accessible by dialling + 46 (0) 8 598 062 47. The slide presentation will be available at:, on Friday, February 10 at 10.00 a.m. Q-Med’s year-end report will be published around 08:00 a.m Friday, February 10. Financial information from Q-Med during Year 2006: 3 May Interim Report January – March 2006 3 May Annual General Meeting 24 July Interim Report January – June 2006 23 October Interim Report January - September 2006 Queries should be addressed to: Anne Rhenman, Director Investor Relations & Corporate Communications Tel: +46 (0) 70 974 90 15 Note: Q-Med AB operates under the name of Q-Med Scandinavia, Inc. in the USA.

About Us

Q-Med is a rapidly growing and profitable biotechnology and medical device company that develops, produces and markets medical implants. Operations focus on four areas, Esthetics, Orthopedics, Uro-Gynecology, and Cell Therapy and Encapsulation.


Documents & Links